GMS Inc
NYSE:GMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GMS Inc
NYSE:GMS
|
US |
|
A
|
Alkaline Water Company Inc
CNSX:WTER
|
US |
|
Lyell Immunopharma Inc
NASDAQ:LYEL
|
US |
|
Avalon Advanced Materials Inc
TSX:AVL
|
CA |
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
CA |
|
Neurogene Inc
NASDAQ:NGNE
|
US |
|
Impax Asset Management Group PLC
LSE:IPX
|
UK |
|
O
|
Opticept Technologies AB
STO:OPTI
|
SE |
|
C
|
China Star Food Group Ltd
SGX:42W
|
SG |
|
ANZ Group Holdings Ltd
OTC:ANZGF
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GMS's stock price target?
Not Available
GMS doesn't have any price targets made by Wall Street professionals.
What is GMS Inc's Revenue forecast?
Projected CAGR
3%
For the last 13 years the
compound annual growth rate for
GMS Inc's revenue is
14%.
The projected
CAGR
for the next 2 years is
3%.
What is GMS Inc's Operating Income forecast?
Projected CAGR
13%
For the last 13 years the
compound annual growth rate for
GMS Inc's operating income is
37%.
The projected
CAGR
for the next 2 years is
13%.
What is GMS Inc's Net Income forecast?
Projected CAGR
57%
The
compound annual growth rate
of GMS Inc's net income for the next 2 years is
57%.
